» Articles » PMID: 35175562

Vascular Endothelial Growth Factor Augments the Tolerance Towards Cerebral Stroke by Enhancing Neurovascular Repair Mechanism

Overview
Publisher Springer
Date 2022 Feb 17
PMID 35175562
Authors
Affiliations
Soon will be listed here.
Abstract

The breakdown of the blood-brain barrier (BBB) is a critical event in the development of secondary brain injury after stroke. Among the cellular hallmarks in the acute phase after stroke are a downregulation of tight-junction molecules and the loss of microvascular pericyte coverage and endothelial sealing. Thus, a rapid repair of blood vessel integrity and re-stabilization of the BBB is considered an important strategy to reduce secondary brain damage. However, the mechanisms underlying BBB disruption remain poorly understood. Especially, the role of VEGF in this context remains inconclusive. With the conditional and reversible VEGF expression systems, we studied the time windows of deleterious and beneficial VEGF actions on blood vessel integrity in mice. Using genetic systems for gain of function and loss of function experiments, we activated and inhibited VEGF signaling prior and simultaneously to ischemic stroke onset. In both scenarios, VEGF seems to play a vital role in containing the stroke-induced damage after cerebral ischemia. We report that the transgenic overexpression of VEGF (GOF) prior to the stroke stabilizes the vasculature and prevents blood-brain barrier disruption in young and aged animals after stroke. Whereas inhibition of signals for endogenous VEGF (LOF) prior to stroke results in bigger infarction with massive brain swelling and enhanced BBB permeability, furthermore, activating or blocking VEGF signaling after ischemic stroke onset had comparable effects on BBB repair and cerebral edema. VEGF can function as an anti-permeability factor, and a VEGF-based therapy in the context of stroke prevention and recovery has an enormous potential.

Citing Articles

Beyond wrecking a wall: revisiting the concept of blood-brain barrier breakdown in ischemic stroke.

Castillo-Gonzalez J, Gonzalez-Rey E Neural Regen Res. 2024; 20(7):1944-1956.

PMID: 39254550 PMC: 11691464. DOI: 10.4103/NRR.NRR-D-24-00392.


Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach.

Hu B, Pei J, Wan C, Liu S, Xu Z, Zou Y J Inflamm Res. 2024; 17:4625-4646.

PMID: 39045531 PMC: 11264385. DOI: 10.2147/JIR.S461427.


Evaluation of AAV Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy.

Yadav A, Liang R, Press K, Schmidt A, Shabani Z, Leng K Transl Stroke Res. 2024; .

PMID: 38977637 DOI: 10.1007/s12975-024-01275-4.


Evaluation of Aav Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy.

Yadav A, Liang R, Press K, Schmidt A, Shabani Z, Leng K Res Sq. 2024; .

PMID: 38947073 PMC: 11213183. DOI: 10.21203/rs.3.rs-4469011/v1.


Lifibrate attenuates blood-brain barrier damage following ischemic stroke via the MLCK/p-MLC/ZO-1 axis.

Duan Y, Deng Y, Tang F, Li J Aging (Albany NY). 2024; 16(7):6135-6146.

PMID: 38546384 PMC: 11042934. DOI: 10.18632/aging.205692.


References
1.
Donkor E . Stroke in the 21 Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke Res Treat. 2019; 2018:3238165. PMC: 6288566. DOI: 10.1155/2018/3238165. View

2.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

3.
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M . Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996; 380(6573):435-9. DOI: 10.1038/380435a0. View

4.
Ferrara N . Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004; 25(4):581-611. DOI: 10.1210/er.2003-0027. View

5.
Ferrara N, Chen H, Dowd M, Lu L, OShea K, Hillan K . Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996; 380(6573):439-42. DOI: 10.1038/380439a0. View